Not a chatbot. Not a search tool. sAÏmone is a strategic intelligence system that takes a natural-language brief and produces structured, multi-workstream output — the kind that traditionally requires months of work from specialised consulting teams.
Pipeline tracking, evidence mapping, and competitive positioning across therapeutic areas. A similarity engine identifies strategic parallels between compounds, mechanisms, and market dynamics.
Structured analysis across clinical trials, publications, congress abstracts, and regulatory filings — with full citations. Extracts endpoints, hazard ratios, and p-values directly from source data.
Strategic Summary for leadership, Operational Handbook for field teams, Medical Writer Handoff, Compliance Extract with evidence grading, and MSL Field Guide — all traceable to the same evidence base, restructured for each audience.
Follows a five-phase Medical Affairs Plan of Strategies methodology: context enrichment, landscape analysis, strategic assessment, tactical recommendations, and execution planning.
Queries PubMed, ClinicalTrials.gov, EU CTIS, WHO ICTRP, FDA, EMA, NICE, and regional registries across LATAM and Asia-Pacific. MeSH term expansion ensures comprehensive retrieval.
A persistent session architecture tracks context, manages deliverable state, and coordinates multi-agent workflows — maintaining coherence across extended, multi-phase analysis runs.
Probabilistic scenario modelling for regulatory timelines, competitive launch sequences, and market access pathways. Quantifies uncertainty across thousands of simulations.
A native desktop application with local session storage. Your data stays on your machine. GDPR-compliant by architecture. Exports directly to Word and PDF.
Every output includes source citations, confidence qualifiers, and a compliance footer. Regulatory claims are validated against source agencies.
At the core of sAÏmone sits a structured knowledge base encoding pharmaceutical Medical Affairs domain logic: strategic pillars, tactical taxonomies, stakeholder profiles, evidence hierarchies, and metric definitions — all with explicit interdependencies, constraint rules, and feasibility gates. This is not learned from training data. It is authored, validated, and deterministic.
Every output passes through a multi-step constraint chain. Stakeholder access levels gate which tactics are eligible. Tactics must align with their parent strategic pillars. Claims are capped by evidence source tiers — a regulatory approval claim requires tier-one regulatory sources, not inferred data. If any link in the chain breaks, the output is blocked. This is how hallucination is structurally prevented, not just discouraged.
Every data point carries an explicit verification status: verified against primary sources, inferred from validated data, or flagged for internal confirmation. A four-tier evidence hierarchy governs what each source is allowed to claim — peer-reviewed publications support outcome-level claims, while preprints are limited to activity-level observations. Cross-validation rules require multi-source confirmation for critical assertions.
Beyond qualitative frameworks, sAÏmone runs live quantitative analysis within sessions: Monte Carlo simulations for regulatory timeline uncertainty, game-theoretic modelling for competitive scenarios, decision-theoretic reasoning under incomplete information, and mechanism design for incentive structuring. These are not summaries of theory — they are executable computational models producing probability-weighted recommendations.
What used to take 6–12 weeks of consultant engagement is delivered in one structured session — with full evidence traceability.
Strategic Summary, Operational Handbook, Medical Writer Handoff, Compliance Extract, and MSL Field Guide — distilled, not regenerated.
Plans live, sleep, and wake up. Programmes go dormant for weeks and reactivate with full strategic memory intact.

Market access, KOL mapping, regulatory status, and evidence positioning across 12 agencies

EU-authorised product comparison with modality, regulatory status, and reimbursement by country

Evidence gaps mapped to PCIPO priorities with specific Medical Affairs actions for each gap

Live-validated context, master narrative, quality checklist, and compliance grading

Decision-theoretic analysis with assumptions, confidence qualifiers, and inter-model sandbox

Regulatory access context, reimbursement verification, data limitations flagged with source URLs for audit

Live computational analysis modelling uncertainty across thousands of scenario iterations

Persistent session architecture — context tracking and multi-agent workflow coordination
sAÏmone is currently available through direct engagements with Medical Affairs teams. We're happy to walk you through the platform and what it produces.
Whether you're exploring AI tools for Medical Affairs, looking to improve your competitive intelligence workflow, or simply want to see a demo — we'd welcome the conversation.
saimone.avti@gmail.com